1.
Ther Innov Regul Sci
; 52(6): 687-688, 2018 11.
Artículo
en Inglés
| MEDLINE
| ID: mdl-30149734
RESUMEN
A consortium of seven pharma companies has been formed with the aim of sharing knowledge on and harmonizing approaches to oligonucleotide development. This letter aims to raise awareness of this new group and to set expectations for future publications.